Literature DB >> 630789

Fluoxetine, a selective serotonin uptake inhibitor.

L Lemberger, H Rowe, R Carmichael, R Crabtree, J S Horng, F Bymaster, D Wong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630789     DOI: 10.1002/cpt1978234421

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

1.  Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

Authors:  T A Lasher; J C Fleishaker; R C Steenwyk; E J Antal
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Cloning of the cocaine-sensitive bovine dopamine transporter.

Authors:  T B Usdin; E Mezey; C Chen; M J Brownstein; B J Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.

Authors:  S B Ross; H Hall; A L Renyi; D Westerlund
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  The effect of PK5078, a new serotonin uptake inhibitor, on serotonin levels and uptake in human platelets, following administration to healthy volunteers.

Authors:  M Kenny; T J Lenehan; R Lambe; I Brick; A Darragh; C Maulet
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers.

Authors:  M Kenny; T J Lenehan; R Lambe; A Darragh; I Brick; L M Omer
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.

Authors:  S B Ross; B Aperia; J Beck-Friis; S Jansa; L Wetterberg; A Aberg
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

Review 7.  Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Authors:  B A Sproule; C A Naranjo; K E Brenmer; P C Hassan
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

8.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

Authors:  I Lemaire; R Tseng; S Lemaire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.

Authors:  C M Villalón; E Ramírez-San Juan; C Castillo; E Castillo; F J López-Muñoz; J A Terrón
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.